Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 9, 2004

View Archived Issues

Histone deacetylase inhibitor effective against esophageal carcinoma in vitro

Genzyme to buy back certain Synvisc rights from Wyeth

Novel macrolides effective against multiresistant strains of pneumococci and H. influenzae

New approval for Eloxatin

Phenoxodiol receives fast track status for recurrent ovarian cancer

Ferrer to distribute Barrier's products

Treatment of multifactor anemia by hypoxia-inducible factor inhibitor

Phase II trials in Canada, E.U. evaluate AMD-3100 for stem cell transplantation

Dynogen acquires pumosetrag from Mitsubishi Pharma

Norditropin approved for adults with severe growth hormone deficiency

CytoGenix submits pre-IND brief for antiherpes drug CY-301

Add-on therapy with Reverset reduces viral load in HIV-infected patients

GX-015-070 enters phase I

Inspire licenses novel glaucoma technology

AstraZeneca to resubmit Symbicort Single Inhaler Therapy file in E.U.

Marqibo submitted for marketing approval in Canada

Phase II data support 873140 as an antiviral for HIV infection

Affimed Therapeutics and Syngenta to codevelop Tandab antibody

Results of PROTECT trial of Integrilin

New data on the benefits of Ampligen in chronic fatigue syndrome

Rifalazil shows promise in the treatment of Chlamydia infections

New data on the pharmacokinetics and tolerability of the neuromuscular blocker AV-430A

Long-term benefits of ranibizumab in neovascular AMD patients

Improved visual acuity found with ruboxistaurin in DME involving the center of macula

New PPARgamma activators and their use in type 2 diabetes and metabolic syndrome

Indian researchers isolate new cytotoxic terpenes from plants

New chiral antiarrhythmic agent covered by Aventis patent

ARS scientists prepare and test novel amylin antiaggregatory peptides

New cathepsin S inhibitors in early development at Boehringer Ingelheim

New elastase release inhibitors described by Taisho and U. of Texas scientists

Adolor claims novel opioid antagonists for use in GI disorders

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...